Matthew Conron

4.4k total citations · 1 hit paper
54 papers, 2.4k citations indexed

About

Matthew Conron is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Matthew Conron has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Matthew Conron's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Matthew Conron is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Matthew Conron collaborates with scholars based in Australia, United Kingdom and United States. Matthew Conron's co-authors include Gavin Wright, Prudence A. Russell, Zoe Wainer, Marissa Daniels, Richard A. Williams, Anne E. Holland, Christine F. McDonald, Catherine J. Hill, P Munro and Alexander Dobrovic and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and British Journal of Cancer.

In The Last Decade

Matthew Conron

53 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

2011 473 citations Prudence A. Russell, Zoe Wainer et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Conron Australia	22	1.7k	628	308	284	262	54	2.4k
Thomas A. Sporn United States	27	2.0k 1.2×	463 0.7×	337 1.1×	232 0.8×	111 0.4×	88	2.7k
William G. Hocking United States	18	1.4k 0.8×	613 1.0×	222 0.7×	418 1.5×	127 0.5×	48	2.3k
Chukwumere Nwogu United States	27	1.7k 1.0×	676 1.1×	269 0.9×	276 1.0×	156 0.6×	91	2.5k
Reury-Perng Perng Taiwan	26	1.6k 0.9×	1.1k 1.7×	365 1.2×	197 0.7×	179 0.7×	78	2.3k
Sow-Hsong Kuo Taiwan	25	1.2k 0.7×	434 0.7×	423 1.4×	206 0.7×	195 0.7×	70	2.1k
Domenico Ferrigno Italy	28	1.2k 0.7×	1.3k 2.1×	434 1.4×	239 0.8×	175 0.7×	85	2.4k
Muzaffer Metintaş Türkiye	30	1.8k 1.1×	207 0.3×	196 0.6×	272 1.0×	152 0.6×	131	2.4k
Duk Hyoung Lee South Korea	11	764 0.5×	881 1.4×	314 1.0×	149 0.5×	209 0.8×	12	2.2k
R.M. Rudd United Kingdom	27	2.0k 1.2×	1.1k 1.7×	470 1.5×	106 0.4×	246 0.9×	70	2.8k
Rakesh Kapoor India	24	756 0.5×	528 0.8×	381 1.2×	217 0.8×	328 1.3×	238	2.4k

Countries citing papers authored by Matthew Conron

Since Specialization

Citations

This map shows the geographic impact of Matthew Conron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Conron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Conron more than expected).

Fields of papers citing papers by Matthew Conron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Conron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Conron. The network helps show where Matthew Conron may publish in the future.

Co-authorship network of co-authors of Matthew Conron

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Conron. A scholar is included among the top collaborators of Matthew Conron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Conron. Matthew Conron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pham, Jonathan, Tiffany Lin, Eldho Paul, et al.. (2025). Disparities in Timeliness and Guideline‐Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer Patients. Asia-Pacific Journal of Clinical Oncology. 22(1). 88–98.

Billah, Baki, Md Nazmul Karim, Phillip Antippa, et al.. (2024). Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator. Clinical Lung Cancer. 25(8). e466–e478. 2 indexed citations

Fairley, Jessica, Laura Ross, Andrew Burns, et al.. (2023). Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease. Internal Medicine Journal. 53(10). 1919–1924. 4 indexed citations

Rathi, Vivek, et al.. (2021). Genomic and Clinical Significance of Multiple Primary Lung Cancers as Determined by Next-Generation Sequencing. Journal of Thoracic Oncology. 16(7). 1166–1175. 30 indexed citations

Heywood, Sophie, et al.. (2021). Physiotherapy-assisted prone or modified prone positioning in ward-based patients with COVID-19: a retrospective cohort study. Physiotherapy. 114. 47–53. 6 indexed citations

Barnett, Stephen, Douglas Johnson, Simon Knight, et al.. (2018). Outcomes following resection of non‐small cell lung cancer in octogenarians. ANZ Journal of Surgery. 88(12). 1322–1327. 12 indexed citations

Clay, Timothy, Prudence A. Russell, Hoang Dang Khoa, et al.. (2015). Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations. Pathology. 48(1). 17–24. 12 indexed citations

Le, Brian, Linda Mileshkin, Odette Spruyt, et al.. (2014). Acceptability of Early Integration of Palliative Care in Patients with Incurable Lung Cancer. Journal of Palliative Medicine. 17(5). 553–558. 46 indexed citations

Stirling, Rob G., Sue Evans, Jeremy Millar, et al.. (2014). The Victorian Lung Cancer Registry Pilot: Improving the Quality of Lung Cancer Care Through the Use of a Disease Quality Registry. Lung. 192(5). 749–758. 43 indexed citations

10.

Russell, Prudence A., Stephen Barnett, Marzena Walkiewicz, et al.. (2013). Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients. Journal of Thoracic Oncology. 8(4). 461–468. 97 indexed citations

11.

Steinfort, Daniel, Danny Liew, Matthew Conron, Anastasia Hutchinson, & Louis Irving. (2010). Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer: A Decision Tree Sensitivity Analysis. Journal of Thoracic Oncology. 5(10). 1564–1570. 62 indexed citations

12.

Steinfort, Daniel, Matthew Conron, Alpha Tsui, et al.. (2010). Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Evaluation of Suspected Lymphoma. Journal of Thoracic Oncology. 5(6). 804–809. 111 indexed citations

13.

Holland, Anne E., Catherine J. Hill, Matthew Conron, P Munro, & Christine F. McDonald. (2009). Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respiratory Medicine. 103(10). 1430–1435. 111 indexed citations

14.

Conron, Matthew, et al.. (2009). Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians. Internal Medicine Journal. 40(7). 494–502. 6 indexed citations

15.

Newnham, Genni M, David M. Thomas, Sue Anne McLachlan, Gavin Wright, & Matthew Conron. (2008). Molecular Profiling of Non-Small Cell Lung Cancer: Of What Value in Clinical Practice?. Heart Lung and Circulation. 17(6). 451–462. 1 indexed citations

16.

Caddy, Grant R., et al.. (2005). The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. European Respiratory Journal. 25(3). 410–415. 46 indexed citations

17.

Sahhar, Joanne, Geoffrey Littlejohn, & Matthew Conron. (2004). Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment. Internal Medicine Journal. 34(11). 626–638. 13 indexed citations

18.

Conron, Matthew, Evangelos Andreakos, Clive Smith, et al.. (2002). Nuclear Factor- κ B Activation in Alveolar Macrophages Requires I κ B kinase- β, but Not Nuclear Factor- κ B Inducing Kinase. American Journal of Respiratory and Critical Care Medicine. 165(7). 996–1004. 17 indexed citations

19.

Glaspole, Ian, Matthew Conron, & R M du Bois. (2000). Clinical features of diffuse parenchymal lung disease. 5(14). 1–14. 5 indexed citations

20.

Conron, Matthew, et al.. (2000). Calcium metabolism in sarcoidosis and its clinical implications. Lara D. Veeken. 39(7). 707–713. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact